학술논문
311 Treatment of bullous pemphigoid by inhibiting fcrn: Pre-registration report of a phase 2/3 trial with efgartigimod
Document Type
Abstract
Author
Source
In Journal of Investigative Dermatology August 2022 142(8) Supplement:S53-S53
Subject
Language
ISSN
0022-202X